Results 131 to 140 of about 19,142 (214)

Kidney Effectiveness and Safety of Adding Spironolactone in Patients With Type 2 Diabetes Receiving Renin–Angiotensin System Inhibitors Therapy

open access: yesClinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT We evaluated the renal outcomes and safety of spironolactone added to renin–angiotensin system inhibitors (RASis) among patients with type 2 diabetes (T2D), given its uncertain role alongside RASis, the cornerstone of T2D with renal disease management.
Wei‐Ren Lin   +7 more
wiley   +1 more source

Prevalence of Tricuspid Regurgitation and Mortality Outcomes in Patients With Heart Failure: Stratification by Phenotype. [PDF]

open access: yesJACC Adv
Mattig I   +9 more
europepmc   +1 more source

Consensus Statement on Practical Guidance for Optimizing Antihypertensive Therapy in Older Adults Needing Nursing Care by the Japan Geriatrics Society and the Japanese Society of Hypertension: English Translation of the Japanese Article

open access: yesGeriatrics &Gerontology International, Volume 26, Issue 3, March 2026.
This Consensus Statement outlines management for nursing care‐dependent older adults (Categories 3–4). Key principles include prioritizing QOL over strict BP targets, avoiding reduction of SBP < 120 mmHg, and implementing stepwise deprescribing. It also emphasizes safety protocols during bathing and rehabilitation to prevent adverse event.
Yoshio Iwashima   +7 more
wiley   +1 more source

Pulmonary Hypertension in HFpEF and HFrEF

open access: yesJournal of the American College of Cardiology, 2020
Marco Guazzi, Stefano Ghio, Yochai Adir
openaire   +1 more source

Phenotyping of acute heart failure with preserved ejection fraction: real‐world outcomes in a cohort of older patients

open access: yesInternal Medicine Journal, Volume 56, Issue 3, Page 373-382, March 2026.
Abstract Background Previous studies have identified distinct subgroups (phenogroups) of patients with heart failure with preserved ejection fraction (HFpEF). Aims This study aims to identify distinct phenotypes in older patients with HFpEF hospitalised for acute heart failure (AHF) and investigate the relationship between subgroups and outcomes ...
Maria Livia Burzo *   +10 more
wiley   +1 more source

EuroSCORE II: Current limitations and physiological gaps in risk stratification

open access: yesExperimental Physiology, Volume 111, Issue 3, Page 1069-1080, 1 March 2026.
Abstract Risk stratification remains critical in cardiac surgery, enabling clinicians to predict adverse outcomes and guide perioperative management. The European System for Cardiac Operative Risk Evaluation (EuroSCORE) II, introduced in 2011, incorporates 18 key variables to provide an evidence‐based approach to risk assessment.
Jing Yong Ng   +7 more
wiley   +1 more source

Leveraging the Translational Science Benefits Model to plan and measure early impact in the heart failure polypill implementation trial in Sri Lanka. [PDF]

open access: yesJ Clin Transl Sci
Hively A   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy